About GRAIL, Inc.
https://grail.comGRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.
CEO
Robert P. Ragusa
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 135
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:2.46M
Value:$258.18M
PRIMECAP MANAGEMENT CO/CA/
Shares:2.02M
Value:$211.69M
CRCM LP
Shares:1.84M
Value:$193.02M
Summary
Showing Top 3 of 362
About GRAIL, Inc.
https://grail.comGRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $36.19M ▲ | $111.56M ▼ | $-88.98M ▲ | -245.83% ▲ | $-2.46 ▲ | $-79.74M ▲ |
| Q2-2025 | $35.54M ▲ | $141.08M ▲ | $-113.98M ▼ | -320.69% ▲ | $-3.18 ▼ | $-91.68M ▲ |
| Q1-2025 | $31.84M ▼ | $133.68M ▲ | $-106.21M ▼ | -333.61% ▼ | $-3.1 ▼ | $-114.33M ▼ |
| Q4-2024 | $38.25M ▲ | $120.97M ▼ | $-97.07M ▲ | -253.75% ▲ | $-2.89 ▲ | $-97.5M ▲ |
| Q3-2024 | $28.65M | $161.27M | $-125.69M | -438.67% | $-3.94 | $-144.28M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $540.13M ▼ | $2.6B ▼ | $361.07M ▼ | $2.24B ▼ |
| Q2-2025 | $602.75M ▼ | $2.7B ▼ | $387.91M ▼ | $2.31B ▼ |
| Q1-2025 | $674.58M ▼ | $2.85B ▼ | $433.94M ▼ | $2.41B ▼ |
| Q4-2024 | $763.47M ▼ | $2.98B ▼ | $479.9M ▼ | $2.5B ▼ |
| Q3-2024 | $853.55M | $3.12B | $530.32M | $2.59B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-88.98M ▲ | $-63.24M ▲ | $66.67M ▼ | $0 | $3.09M ▲ | $-63.63M ▲ |
| Q2-2025 | $-113.98M ▼ | $-76.97M ▲ | $70.37M ▲ | $0 | $-6.47M ▲ | $-77.33M ▲ |
| Q1-2025 | $-106.21M ▼ | $-95.01M ▼ | $14.61M ▲ | $0 | $-80.34M ▲ | $-95.07M ▼ |
| Q4-2024 | $-97.07M ▲ | $-93.49M ▲ | $-546.11M ▼ | $0 | $-639.89M ▼ | $-93.79M ▲ |
| Q3-2024 | $-125.69M | $-104.58M | $-971K | $0 | $-105.29M | $-105.55M |
Revenue by Geography
| Region | Q3-2025 | Q2-2025 | Q1-2025 |
|---|---|---|---|
 Americas | $0 ▲ | $0 ▲ | $30.00M ▲ |
 NonUS | $0 ▲ | $0 ▲ | $0 ▲ |
 UNITED STATES | $30.00M ▲ | $30.00M ▲ | $0 ▼ |
CEO
Robert P. Ragusa
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 135
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:2.46M
Value:$258.18M
PRIMECAP MANAGEMENT CO/CA/
Shares:2.02M
Value:$211.69M
CRCM LP
Shares:1.84M
Value:$193.02M
Summary
Showing Top 3 of 362